Natera

Groundbreaking Verdict: Delaware Jury Grants Natera $96.3m in Damages for Pioneering Kidney Transplant Tests

by

Wilmington, Delaware – A Delaware jury has awarded Natera $96.3 million in damages in a lawsuit concerning kidney transplant tests. The jury’s decision came after a dispute over the alleged theft of the intellectual property from Natera by CoGenesys, a former business partner. This ruling represents a significant victory for Natera, a global leader in genetic testing and diagnostics. The jury found CoGenesys liable for breach of contract, misappropriation of trade secrets, and fraud. According to the evidence presented during the trial, CoGenesys unlawfully obtained Natera’s proprietary technology and used it to develop their own … Read more

Natera Acquitted of Willful Infringement in Ravgen Case – Landmark Verdict Delivers Favorable Outcome

by

REDWOOD CITY, California – Natera, a leading genetic testing company, announced that a jury has reached a verdict of no willful infringement in the Ravgen case. The verdict concludes a month-long trial that centered around allegations of patent infringement relating to noninvasive prenatal testing technology. The case involved Ravgen, a small genetic testing company, accusing Natera of willfully infringing on two of its patents. Ravgen claimed that Natera had used its patented technology to develop and market its own noninvasive prenatal testing products. The jury, however, ruled in favor of Natera, stating that the company … Read more